Royalty Report: Drugs, Cancer, Disease – Collection: 286069

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Drugs
  • Cancer
  • Disease
  • Assay
  • Diagnostic
  • Pharmaceuticals
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 286069

License Grant
The University grants to the Canadian Licensee an exclusive license under Licensed Subject Matter to manufacture, have manufactured, use and/or sell licensed products within licensed territory for use within licensed field and, will extend to Universitys undivided interest in any licensed subject matter developed during the term of this agreement and jointly owned by University and Licensee.
License Property
Licensed subject matter means inventions and discoveries covered by patent rights or technology rights within licensed Field.

Technology rights shall mean University rights in any technical information, know-how, processes, procedures, compositions, devices, methods, formulae, protocols, techniques, software, designs, drawings or data created by the inventors before the Effective Date relating to the use of liposomal vinca alkaloids which are not covered by patent rights but which are necessary for practicing the inventions covered patent rights.

The patents are for The Use of Liposomal Vincristine in Order to Circumvent Toxicity and Allow Administration of Higher Doses of Drug, and,  Compositions and Methods for Treating Lymphoma.

Field of Use
The licensed field means cancer therapy.

IPSCIO Record ID: 223108

License Grant
The Board, through Licensor, hereby grants to Licensee a royalty-bearing, exclusive license under Licensed Subject Matter to manufacture, have manufactured, use, import, offer to sell and/or sell Licensed Products within Licensed Territory for use within Licensed Field.
License Property
Licensed Subject Matter means inventions and discoveries covered by Patent Rights or Technology Rights within Licensed Field.

Licensed Products means any product or service sold by Licensee comprising Licensed Subject Matter pursuant to this Agreement.

Derived Product means any service or product, whether or not a Licensed Product, that utilizes or is based on biological markers, proteins or other proteomic information (including, but not limited to, protein fractions, protein patterns and protein profiles) identified, discovered, analyzed, developed or otherwise derived or made  possible using licensed subject matter, patent rights and/or technology rights.

Technology rights means Boards rights in any technical information, know-how, processes, procedures, compositions, devices, methods, formulae, protocols, techniques, software, designs, drawings or data created by the inventor(s) listed below (*) before the effective date, which are not claimed in patent rights but that are necessary for practicing patent rights.

Patent rights means Boards rights in information or discoveries claimed n the patents, and/or patent applications and any letters patent that issue thereon, whether domestic or foreign, listed below (*).

(*) MDA03-127 (UTSC874) entitled 'Using Plasma Proteomic Pattern for Diagnosis, Prediction of Response to Therapy and Clinical Behavior, and Monitoring Disease in Hematologic Malignancies,'

Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.

Field of Use
This agreement pertains to the drug industry relating to Diagnosis, Prediction of Response to Therapy and Clinical Behavior, and Monitoring Disease in Hematologic Malignancies in all fields of use.

IPSCIO Record ID: 29195

License Grant
Board hereby grants to Licensee an exclusive license under both Coagulation Patent Rights and Coagulation Technology Rights to manufacture, have manufactured, use, and/or sell Licensed Products.
License Property
Coagulation Technology Rights shall mean Board’s rights in any technical information, know-how, process, procedure, composition, or device, method, formula, protocol, technique, software, design, drawing, data, biological and other materials which are useful in targeting therapeutic and diagnostic compounds to tumor vasculature in humans and which are not covered by Coagulation Patent Rights but which are necessary or useful for practicing any inventions at any time covered by Coagulation Patent Rights.
Field of Use
Licensed Field shall mean targeting compounds to or acting on tumor vasculature or any other component of a tumor for therapeutic or diagnostic use.

IPSCIO Record ID: 203309

License Grant
Licensor grants an exclusive license under Patent Rights and Know-How, to make, use, sell, offer for sale, and import Licensed Products and to practice Licensed Methods in the Field within the Territory and during the Term.
License Property
This agreement is for SDP-012  or vinorelbine.  Licensor has submitted a patent application which describes an invention relating to an emulsion composition for delivering highly water-soluble Vinca Alkaloid Drugs.

Vinca Alkaloid Drug(s) means those certain generic pharmaceutical drugs which are commonly known as vinca alkaloid drugs, including without limitation to vinorelbine.

Licensed Method means any method that is covered by Patent Rights, the use of which would constitute, but for the license granted to Licensee under this Agreement, an infringement of any pending or issued and unexpired claim within Patent Rights.

Licensed Product means any Vinca Alkaloid Drug composition or product that is covered by the claims of Patent Rights, or that is produced by the Licensed Method, or the manufacture, use, sale, offer for sale, or importation of which would constitute, but for the license granted to Licensee by Licensor, an infringement of any pending or issued and unexpired claim within the Patent Rights, for use in the Field.

SDP-012 (vinorelbine) is a chemotherapy medication used to treat a number of types of cancer.

Field of Use
Field means development and use of Vinca Alkaloid Drug formulations for the treatment and/or prevention of human disease.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.